Article
Direct-acting antiviral therapy in HCV patients: a retrospective study of the pre- and post-treatment impact in Saudi Arabia.
BMC infectious diseases - 2 Feb 2026
Alayidh Fatimah Salem, Woodman Alexander, Zakary Nawaf Yahya, Al-Ansari Rehab Yusuf, Chaudhry Sharjeel, Alsaadi Amal Omar, Alharbi Khadijah Ahmad, Alamri Batool Abdullah, Alhomud Shahad Mousa, Albather Shahad Hassan, Bataweel Sarah Abdullah, Madkhali Nouf Ahmed, Alzahrani Samira Jamaan, Ehtesham Zarmina
Abstract excerpt
BACKGROUND: Although direct-acting antiviral (DAA) therapy revolutionized hepatitis C virus (HCV) treatment, offering high cure rates and improved tolerability compared to previous interferon-based regimens, HCV remains a major global health problem, with a lack of empirical data on HCV in Saudi Arabia. This study aims to investigate the current understanding of the clinical impact of DAA on HCV infection by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.